Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Krsnaa Diagnostics Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Low
₹493.20
High
₹509.35
Price Summary
| Previous Close | ₹503.75 |
|---|---|
| Day's Range | ₹493.20 - ₹509.35 |
| Open | ₹497.95 |
| 52 Week Range | ₹483.55 - ₹838.00 |
| Volume | 41,766 |
| Market Cap | ₹0.00 |
| Previous Close | ₹504.10 |
|---|---|
| Day's Range | ₹492.25 - ₹507.25 |
| Open | ₹495.00 |
| 52 Week Range | ₹480.00 - ₹846.55 |
| Volume | 1,199 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 209.58 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.40 |
| Price/Earning (TTM) | 16.78 |
| TTM EPS (₹) | 30.04 |
| P/E Ratio | 16.67 |
| Book Value(₹) | 1.65 |
| PAT Margin (%) | 13.13 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 13.08 |
| Trade Value ( ₹ in Lacs) | 6.03 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.40 |
| Price/Earning (TTM) | 16.78 |
| TTM EPS (₹) | 30.04 |
| P/E Ratio | 16.67 |
| Book Value(₹) | 1.65 |
| PAT Margin (%) | 13.13 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 13.08 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1756.15 | 7171.6 |
| Expenses | N/A | N/A |
| PBT | 263.37 | 1026.87 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 195.62 | 776.08 |
About Krsnaa Diagnostics Ltd.
| Founded | 2010 |
|---|---|
| Managing Director | Yash Mutha |
| NSE Symbol | KRSNAA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,26,661.74 | 1,778.25 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,57,902.73 | 9,715.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,76,306.21 | 4,635.15 | 3,532.60 - 3,532.60 |
| Laurus Labs Ltd. | 1,29,242.68 | 2,392.00 | 917.95 - 917.95 |
| Zydus Lifesciences Ltd. | 1,24,089.48 | 1,244.00 | 835.50 - 835.50 |
| Apollo Hospitals Enterprise Ltd. | 1,20,779.11 | 8,400.00 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,17,959.74 | 678.20 | 0.00 - 0.00 |
| Dr. Reddy's Laboratories Ltd. | 1,12,698.53 | 1,350.20 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,11,488.55 | 1,380.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,02,796.60 | 2,488.75 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Oct
22
2026
Posted on Oct 22nd 2026
Krsnaa Diagnostics informs about press release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III thereto, Krsnaa Diagnostics has informed that it enclosed the press release of the Company titled ‘Krsnaa Diagnostics Announces Strategic AI Collaboration with Global Radiology AI Innovator AZmed, Creating a Platform for Greater Reporting Efficiency and Scalable Growth’. The said press release is also being made available on the website of the Company at https://krsnaadiagnostics.com/investors/.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
16
2026
Posted on Oct 16th 2026
Krsnaa Diagnostics informs about disclosure
Krsnaa Diagnostics has informed that it encclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krsna Diagnostics (Mumbai) & PAC.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
14
2026
Posted on Oct 14th 2026
Krsnaa Diagnostics informs about clarification on allotment of warrants
With reference to intimation dated October 13, 2026 regarding the allotment of fully convertible warrants on a preferential basis, Krsnaa Diagnostics has clarified that, in the said intimation, the premium at which the warrants were allotted was inadvertently mentioned as ₹551 per warrant. The same should be read as ₹561 per warrant. The error is purely typographical and inadvertent, and the Company deeply regrets the same. All other details in the said intimation remain unchanged.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
19
2026
Posted on Sep 19th 2026
Krsnaa Diagnostics informs about updates
Krsnaa Diagnostics has informed regarding the voting results as the outcome of the postal ballot dated September 17, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
19
2026
Posted on Sep 19th 2026
Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report
With reference to its letter no. KDL/SE/032/2026-27 dated August 18, 2026, Krsnaa Diagnostics has informed that it enclosed the Postal Ballot Notice dated August 13, 2026 (‘Notice’) for seeking approval of the shareholders of the Company on special resolution: Approval for Issuance of up to 16,21,000 Warrants Convertible into Equity Shares of Face Value Rs.5/- each on a Preferential Basis to the Promoter and Promoter Group of the Company. Pursuant to Sections 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) read with the Companies (Management and Administration) Rules, 2014, guidelines prescribed by the Ministry of Corporate Affairs through various Circular(s) and the Listing Regulations, as amended from time to time, the Postal Ballot was conducted through remote e-voting process. The remote e-voting process concluded on Thursday, September 17, 2026, at 17:00 Hrs. (IST), post which Dinesh Shivnarayan Birla (Membership No.: FCS-7658, COP: 13029), Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, Company Secretaries, Scrutinizer submitted the Report on the Postal Ballot voting results on September 18, 2026. Based on the Scrutinizer’s Report, the company has informed that the Special Resolution mentioned in the Postal Ballot Notice dated August 13, 2026 has been passed by the Members of the Company with requisite majority on September 17, 2026, i.e., the last date of remote e-voting. In connection with the above, it has enclosed the following: a. Voting results pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Act read with the Companies (Management and Administration) Rules, 2014; and b. Scrutinizer's Report dated September 18, 2026 on remote e-voting.
The above information is a part of company’s filings submitted to BSE.
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Krsnaa Diagnostics Ltd. is ₹503.75 as of 2026-10-30.
The market capitalisation of Krsnaa Diagnostics Ltd. is ₹1,635.23 as of 2026-10-30.
The 1-year return of Krsnaa Diagnostics Ltd. is -272.95% as of 2026-10-30.
The P/E ratio of Krsnaa Diagnostics Ltd. is 16.67 as of 2026-11-01.
The 52-week high and low of Krsnaa Diagnostics Ltd. are ₹838.00 and ₹483.55, respectively, as of 2026-10-30.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
